NCT03355365: A trial that was reported late by Tisch Multiple Sclerosis Research Center of New York
This trial has reported, although it was 376 days late in doing so.
Full data
Full entry on ClinicalTrials.gov | NCT03355365 |
---|---|
Title | Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally |
Results Status | Reported (late) |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | Sept. 21, 2018 |
Completion date | Feb. 9, 2023 |
Required reporting date | Feb. 9, 2024, midnight |
Actual reporting date | Feb. 19, 2025 |
Date last checked at ClinicalTrials.gov | Aug. 12, 2025 |
Days late | 376 |